Close Menu

NEW YORK (GenomeWeb) — Cofactor Genomics announced today that its ImmunoPrism Immune Profiling kit will be used in a Phase I/IIa clinical study of Genocea Biosciences' personalized cancer vaccine candidate GEN-009.

Launched in October, the RNA-based kit allows for the preparation, sequencing, and immune composition analysis of solid tumors against Cofactor's database of machine learning-optimized immune reference expression models.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.

Jun
13
Sponsored by
Roche

Ribosomal ribonucleic acid (rRNA) accounts for up to 99 percent of the total RNA depending on the cell type. 

Jun
17
Sponsored by
Illumina

This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.